Literature DB >> 22229446

Increased echocardiographic epicardial fat thickness is related to impaired diurnal blood pressure profiles.

Faruk Ertas1, Hasan Kaya, Halit Acet, Habib Cil, Abdurrahman Akyüz, Yahya Islamoğlu, Ebru Tekbaş, Zuhal Aritürk, Mesut Aydin, Serdar Soydinç.   

Abstract

OBJECTIVE: Epicardial fat has been proposed as a new cardiometabolic risk factor. Although epicardial fat thickness (EFT) is associated with hypertension, the relationship between diurnal blood pressure profiles and EFT is still unknown. The purpose of this study is to investigate the association between the echocardiographic EFT and diurnal blood pressure profiles in hypertensive patients.
METHODS: After the ambulatory blood pressures of 123 patients were monitored, they were divided into three groups according to the clinical diagnoses: 41 patients (33.3%) were in the normotensive group, 40 patients (32.5%) were in the dipper hypertensive group and 42 patients (34.1%) were in the non-dipper hypertensive group. All participants underwent transthoracic echocardiography and ambulatory blood pressure monitoring to measure the EFT and blood pressure responses.
RESULTS: The mean EFT measurements of the dipper group were significantly higher than the normotensive group (6.5 ± 0.6 vs 5.8 ± 0.6; p < 0.0001). On the other hand, the mean EFTs of the non-dipper group were also significantly higher than the dipper group (7.4 ± 0.7 vs 6.5 ± 0.6, p < 0.0001). An EFT of ≥ 7 mm predicted the non-dipper profile in hypertensive patients with 74% sensitivity and 71% specificity (receiving operator characteristic area under the curve: 0.826, 95% CI 0.738-0.913; p < 0.0001). EFT was associated with both dipper (OR 8.9, 95% CI 3.03-26.3; p < 0.0001) and non-dipper blood pressure profiles (OR 12.3, 95% CI 1.75-86.31; p < 0.0001), and this relationship was also independent from all the risk factors.
CONCLUSION: Echocardiographic EFT assessment is independently associated with impaired diurnal blood pressure profiles in the hypertensive individuals. Thus, the echocardiographic assessment of the EFT may be helpful in cardiometabolic risk stratification and therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22229446     DOI: 10.3109/08037051.2011.649538

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


  6 in total

1.  Determination of UCP1 expression in subcutaneous and perirenal adipose tissues of patients with hypertension.

Authors:  Xueqin Li; Juan Liu; Gongcheng Wang; Jing Yu; Yunlu Sheng; Chen Wang; Yifan Lv; Shan Lv; Hanmei Qi; Wenjuan Di; Changjun Yin; Guoxian Ding
Journal:  Endocrine       Date:  2015-03-18       Impact factor: 3.633

2.  New inflammatory predictors for non-valvular atrial fibrillation: echocardiographic epicardial fat thickness and neutrophil to lymphocyte ratio.

Authors:  Halit Acet; Faruk Ertaş; Mehmet Ata Akıl; Mustafa Oylumlu; Nihat Polat; Abdulkadir Yıldız; Mehmet Zihni Bilik; Murat Yüksel; Zeynettin Kaya; Mehmet Sıddık Ulgen
Journal:  Int J Cardiovasc Imaging       Date:  2013-10-26       Impact factor: 2.357

3.  Epicardial Fat Thickness is Associated with Abnormal Left Ventricle Geometry in Newly Diagnosed Hypertension.

Authors:  Taner Şeker; Caner Türkoğlu; Hazar Harbalıoğlu; Mustafa Gür
Journal:  Acta Cardiol Sin       Date:  2018-05       Impact factor: 2.672

4.  Impact of Gender on the Association of Epicardial Fat Thickness, Obesity, and Circadian Blood Pressure Pattern in Hypertensive Patients.

Authors:  In Kyoung Shim; Kyoung-Im Cho; Hyun-Su Kim; Jung-Ho Heo; Tae Joon Cha
Journal:  J Diabetes Res       Date:  2015-04-30       Impact factor: 4.011

5.  Maximal pericoronary adipose tissue thickness is associated with hypertension in nonobese patients with acute or chronic illness.

Authors:  Shinhae Chang; Wangjin Lee; Byounggyu Kwag; Yun Hee Chung; In Sook Kang
Journal:  Korean J Intern Med       Date:  2016-12-06       Impact factor: 2.884

6.  Increased epicardial adipose tissue thickness as a predictor for hypertension: a cross-sectional observational study.

Authors:  Dror Dicker; Eli Atar; Ran Kornowski; Gil N Bachar
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-09-19       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.